SW
NAGE

SteelPeak Wealth’s Niagen Bioscience NAGE Stock Holding History

SteelPeak Wealth’s Portfolio NAGE Stock Details NAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.2M Buy
3,500,129
+127,129
+4% +$516K 0.29% 78
2026
Q1 		$14.9M Buy
+3,373,000
New +$18.2M 0.45% 57

Other funds holding NAGE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tieton Capital Management Yakima, Washington $348M AUM 45.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SteelPeak Wealth's NAGE Position: Q2 2026 in Review

SteelPeak Wealth increased its Niagen Bioscience (NAGE) stake by 3.8% in Q2 2026, buying an estimated $516K and bringing the position to 3,500,129 shares worth $11.2M. The position accounts for 0.29% of the portfolio, ranked #78.

SteelPeak Wealth first reported a position in NAGE in Q1 2026 and has held it in 2 quarters since. The position peaked at $14.9M in Q1 2026. 140 funds tracked by Wall St. Rank hold NAGE as of Q2 2026.

  • SteelPeak Wealth held 3,500,129 shares of Niagen Bioscience worth $11.2M as of Q2 2026.
  • SteelPeak Wealth bought 127,129 Niagen Bioscience shares in Q2 2026, an estimated $516K.
  • Niagen Bioscience made up 0.29% of SteelPeak Wealth's portfolio in Q2 2026, its #78 holding.
  • SteelPeak Wealth first reported a position in Niagen Bioscience in Q1 2026 and has held it in 2 quarters since.
  • SteelPeak Wealth's Niagen Bioscience position peaked at $14.9M in Q1 2026.
  • 140 funds tracked by Wall St. Rank held Niagen Bioscience as of Q2 2026.

Based on SteelPeak Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.